Senior Indian Administrative Service (IAS) officer, Manoj Joshi, has assumed charge as the Secretary of the Department of Pharmaceuticals (DoP) under the Ministry of Chemicals and Fertilisers, following approval by the Appointments Committee of the Cabinet (ACC).

A 1989-batch IAS officer of the Kerala cadre, Joshi, joins the Department of Pharmaceuticals after serving as Secretary, Department of Land Resources in the Ministry of Rural Development. He succeeds Amit Aggarwal, who has been appointed as the Secretary of the Department of Telecommunications.

Joshi’s appointment comes at a crucial moment for India’s pharmaceutical ecosystem, which is undergoing significant transformation driven by regulatory evolution, capacity expansion, and a renewed emphasis on research-led growth. As Secretary, he will be responsible for steering policy initiatives focused on strengthening domestic pharmaceutical and medical device manufacturing, enhancing ease of doing business, and reinforcing India’s position as a global pharma and medtech hub.

The Department of Pharmaceuticals plays a critical role in designing and implementing flagship schemes aimed at innovation promotion, quality compliance, and investment facilitation across the pharma and medtech value chain. Key priorities include supply chain resilience, manufacturing self-reliance, and alignment with global quality and regulatory standards.

Joshi’s leadership trajectory gains added significance against the backdrop of the India Pharma Expo 2026, scheduled for 23–25 April 2026 at the HITEX Exhibition Centre in Hyderabad, organised by Elets Technomedia with eHealth as a knowledge partner. This leading industry event, themed “India’s Pharma Power: Building Global Bridges in Life Sciences & Innovation” is set to be one of South Asia’s largest gatherings of pharmaceutical and healthcare stakeholders, attracting 15,000+ visitors, 300+ exhibitors, and delegates from over 15 countries. 

Also read: Dr. Tushar Nahata Promoted to Vice President at Zydus Group, Strengthening Leadership in Injectable R&D

As the industry prepares for the Expo’s robust agenda of exhibitions, global panel discussions, and knowledge-sharing sessions, Joshi’s appointment is expected to provide valuable continuity and strategic impetus, bridging government policy priorities with industry aspirations at a time when India’s pharmaceutical ecosystem is poised for accelerated expansion on both domestic and global stages. 

For more information: https://indiapharmaexpo.com/

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!